skip to main content

H.R. 4663: Freedom from Price Gouging Act

Call or Write Congress

To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.

The bill’s titles are written by its sponsor.

Sponsor and status

Katie Porter

Sponsor. Representative for California's 45th congressional district. Democrat.

Read Text »
Last Updated: Oct 11, 2019
Length: 13 pages
Introduced
Oct 11, 2019
Status

Introduced on Oct 11, 2019

This bill is in the first stage of the legislative process. It was introduced into Congress on October 11, 2019. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Prognosis
1% chance of being enacted according to Skopos Labs (details)
Source

History

Oct 11, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

If this bill has further action, the following steps may occur next:
 
Passed Committee

 
Passed House

 
Passed Senate

 
Signed by the President

H.R. 4663 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 4663 — 116th Congress: Freedom from Price Gouging Act.” www.GovTrack.us. 2019. November 22, 2019 <https://www.govtrack.us/congress/bills/116/hr4663>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.